|
EMD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.30430000133686E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.63646873829748E-12 |
| Stage1-vs-Stage2 |
6.132400E-02 |
| Stage1-vs-Stage3 |
1.933220E-01 |
| Stage1-vs-Stage4 |
3.081400E-01 |
| Stage2-vs-Stage3 |
1.622040E-02 |
| Stage2-vs-Stage4 |
5.285700E-02 |
| Stage3-vs-Stage4 |
9.610400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.72833999999567E-05 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
5.813000E-01 |
| Caucasian-vs-Asian |
4.929800E-01 |
| AfricanAmerican-vs-Asian |
4.382600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.120600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63768998362457E-12 |
| Normal-vs-Age(81-100Yrs) |
4.07300000000443E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.764200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.264400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.073600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.972200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.524600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.254200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.66350000000626E-05 |
| Classical-VS-Follicular |
1.000690E-04 |
| Classical-VS-Other |
5.114800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.02499997378658E-09 |
| Tall-VS-Other |
5.799700E-03 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.279000E-01 |
| Follicular-VS-Normal |
4.43939995875553E-09 |
| Other-VS-Normal |
9.73199999999563E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| N0-vs-N1 |
1.021990E-02 |
|
|
